Cryotherapy protocols for metastatic breast cancer after failure of radical surgery

详细信息    查看全文

• 作者：Lizhi Niu ; Feng Mu ; Changming Zhang ; Yongqiang Li ; Weiqun Liu ; Feng Jiang ; Li Li ; Chunyan Liu ; Jianying Zeng ; Fei yao ; Jibing Chen ; Jialiang Li ; Jiansheng Zuo ; Kecheng Xu
• 关键词：Cryotherapy ; Metastatic breast cancer ; Cryo-immunotherapy ; Dendritic cell&ndash ; cytokine-induced killer cell ; Chemotherapy
• 刊名：Cryobiology
• 出版年：2013
• 出版时间：August, 2013
• 年：2013
• 卷：67
• 期：1
• 页码：17-22
• 全文大小：713 K

文摘

To retrospectively assess the effect of cryotherapy in patients with metastatic breast cancer (MBC) but without local recurrence after resection of the primary lesion, we divided 120 MBC patients into cryotherapy (91 patients) and chemotherapy (29 patients) groups. In the cryotherapy group, 37 patients with tumor recurrence received multiple cryoablations, while 54 patients received only a single cryoablation. Moreover, 62 cryotherapy-group patients underwent cryoablation immediately after the detection of metastases (timely cryotherapy); 35 patients received simultaneous immunotherapy (cryo-immunotherapy), and 29 patients underwent cryoablation in our hospital 3 months after receiving chemotherapy in other centers (chemo-cryotherapy and delayed cryotherapy). Overall survival (OS) after the diagnosis of MBC was assessed after a 10-year follow-up. The median OS was higher in the cryotherapy group (55 months) than in the chemotherapy group (27 months; P < 0.0001). In the cryotherapy group, longer median OS was associated with multiple (76 months) rather than single cryoablations (48 months; P = 0.0005) and with timely (67 months) rather than delayed cryoablation (48 months; P = 0.0012). The median OS was higher after cryo-immunotherapy (83 months) than after chemo-cryotherapy (48 months) or cryotherapy alone (43 months; P < 0.0001 for both). In conclusion, timely and multiple cryoablations, especially when combined with immunotherapy, offer significant advantages over chemotherapy in extending the OS of MBC patients.